Basic Information
AVOFER INJECTION 100MG/5ML
INJECTION
Regulatory Information
SIN16513P
June 16, 2022
Prescription Only
Therapeutic
INTRAVENOUS
August 10, 2023
June 3, 2025
XB03AC
Company Information
Active Ingredients
Strength: 100mg/5ml
Detailed Information
Contraindications
**CONTRAINDICATIONS** The use of Avofer is contraindicated in the following conditions: - Hypersensitivity to iron sucrose, Avofer or to any of its excipients listed in section _List of excipients_ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_ - Anaemia not caused by iron deficiency - Evidence of iron overload or disturbances in utilisation of iron - Pregnancy first Trimester
Indication Information
**INDICATIONS** Avofer is indicated in the treatment of iron deficiency in the following indications: ➢ Where there is a clinical need for a rapid iron supply ➢ In patients who cannot tolerate oral iron therapy or who are non-compliant ➢ Where oral iron preparations are ineffective (e.g., in active inflammatory bowel disease). Avofer should only be administered where the indication is confirmed by appropriate investigations.